IncobotulinumtoxinA for the treatment of spasticity in children with cerebral palsy – a retrospective case series focusing on dosing and tolerability

BACKGROUND: IncobotulinumtoxinA (Xeomin®) is a botulinum neurotoxin type A with established efficacy in the treatment of upper-limb spasticity in adults. This retrospective case series in a university hospital setting aimed to elucidate the safety and tolerability of incobotulinumtoxinA for treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: León-Valenzuela, Angel, Palacios, Juan Sánchez, del Pino Algarrada, Rogelio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140581/
https://www.ncbi.nlm.nih.gov/pubmed/32268880
http://dx.doi.org/10.1186/s12883-020-01702-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140581/
https://www.ncbi.nlm.nih.gov/pubmed/32268880
http://dx.doi.org/10.1186/s12883-020-01702-7

Ejemplares similares